• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒依赖性补体激活的物理化学特征

Physicochemical signatures of nanoparticle-dependent complement activation.

作者信息

Thomas Dennis G, Chikkagoudar Satish, Heredia-Langer Alejandro, Tardiff Mark F, Xu Zhixiang, Hourcade Dennis E, Pham Christine T N, Lanza Gregory M, Weinberger Kilian Q, Baker Nathan A

机构信息

Knowledge Discovery and Informatics, Pacific Northwest National Laboratory, Richland, WA 99352, USA.

Applied Statistics and Computational Modeling, Pacific Northwest National Laboratory, Richland, WA 99352, USA.

出版信息

Comput Sci Discov. 2014 Mar 21;7(1):015003. doi: 10.1088/1749-4699/7/1/015003.

DOI:10.1088/1749-4699/7/1/015003
PMID:25254068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4169987/
Abstract

Nanoparticles are potentially powerful therapeutic tools that have the capacity to target drug payloads and imaging agents. However, some nanoparticles can activate complement, a branch of the innate immune system, and cause adverse side-effects. Recently, we employed an tro hemolysis assay to measure the serum complement activity of perfluorocarbon nanoparticles that differed by size, surface charge, and surface chemistry, quantifying the nanoparticle-dependent complement activity using a metric called Residual Hemolytic Activity (RHA). In the present work, we have used a decision tree learning algorithm to derive the rules for estimating nanoparticle-dependent complement response based on the data generated from the hemolytic assay studies. Our results indicate that physicochemical properties of nanoparticles, namely, size, polydispersity index, zeta potential, and mole percentage of the active surface ligand of a nanoparticle, can serve as good descriptors for prediction of nanoparticle-dependent complement activation in the decision tree modeling framework.

摘要

纳米颗粒是具有潜在强大功能的治疗工具,有能力靶向药物有效载荷和成像剂。然而,一些纳米颗粒可激活补体(先天免疫系统的一个分支)并引起不良副作用。最近,我们采用了一种溶血试验来测量不同尺寸、表面电荷和表面化学性质的全氟化碳纳米颗粒的血清补体活性,使用一种称为残余溶血活性(RHA)的指标来量化纳米颗粒依赖性补体活性。在本研究中,我们使用决策树学习算法,根据溶血试验研究产生的数据,推导估算纳米颗粒依赖性补体反应的规则。我们的结果表明,纳米颗粒的物理化学性质,即尺寸、多分散指数、zeta电位和纳米颗粒活性表面配体的摩尔百分比,可作为决策树建模框架中预测纳米颗粒依赖性补体激活的良好描述符。

相似文献

1
Physicochemical signatures of nanoparticle-dependent complement activation.纳米颗粒依赖性补体激活的物理化学特征
Comput Sci Discov. 2014 Mar 21;7(1):015003. doi: 10.1088/1749-4699/7/1/015003.
2
Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.溶血试验在全氟碳纳米颗粒补体激活分析中的应用。
Nanomedicine. 2014 Apr;10(3):651-60. doi: 10.1016/j.nano.2013.10.012. Epub 2013 Nov 8.
3
Development of a Sensitive Assay to Screen Nanoparticles for Complement Activation.一种用于筛选纳米颗粒补体激活的灵敏检测方法的开发。
ACS Biomater Sci Eng. 2020 Sep 14;6(9):4903-4915. doi: 10.1021/acsbiomaterials.0c00722. Epub 2020 Jul 6.
4
Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies.聚乳酸-羟基乙酸共聚物纳米颗粒与血液成分的相互作用:蛋白质吸附、凝血、补体系统激活及溶血研究
Nanoscale. 2015 Apr 14;7(14):6045-58. doi: 10.1039/c5nr00733j.
5
Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation.核壳型甲基丙烯酸甲酯壳聚糖纳米粒:体外黏膜黏附及补体激活。
Daru. 2011;19(4):257-65.
6
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.旨在了解纳米颗粒与免疫系统相互作用及其对纳米颗粒生物分布潜在影响的临床前研究。
Mol Pharm. 2008 Jul-Aug;5(4):487-95. doi: 10.1021/mp800032f. Epub 2008 May 30.
7
CH(50): a revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction.CH(50):一种重新审视的溶血补体消耗检测法,用于评估纳米颗粒与血浆蛋白的相互作用。
Curr Drug Deliv. 2011 May;8(3):290-8. doi: 10.2174/156720111795256165.
8
Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.功能化磷脂纳米粒子表面对补体的可变抗体依赖性激活。
J Biol Chem. 2011 Jan 7;286(1):123-30. doi: 10.1074/jbc.M110.180760. Epub 2010 Nov 3.
9
Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.介孔硅纳米颗粒的尺寸、孔有序性和孔完整性对溶血活性的影响。
J Am Chem Soc. 2010 Apr 7;132(13):4834-42. doi: 10.1021/ja910846q.
10
Method for analysis of nanoparticle hemolytic properties in vitro.纳米颗粒体外溶血特性的分析方法。
Nano Lett. 2008 Aug;8(8):2180-7. doi: 10.1021/nl0805615. Epub 2008 Jul 8.

引用本文的文献

1
Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.影响纳米颗粒向大脑递药的生理和病理因素。
Adv Sci (Weinh). 2021 Jun;8(11):e2002085. doi: 10.1002/advs.202002085. Epub 2021 Mar 15.
2
Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.静脉注射用免疫球蛋白制剂中的亚可见颗粒会在人血清中激活补体。
J Pharm Sci. 2020 Jan;109(1):558-565. doi: 10.1016/j.xphs.2019.10.041. Epub 2019 Oct 28.
3
Recent Advances in Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.全氟碳乳剂在氟磁共振成像中的最新进展
Engineering (Beijing). 2015 Dec;1(4):475-489. doi: 10.15302/J-ENG-2015103. Epub 2016 Mar 16.

本文引用的文献

1
Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.溶血试验在全氟碳纳米颗粒补体激活分析中的应用。
Nanomedicine. 2014 Apr;10(3):651-60. doi: 10.1016/j.nano.2013.10.012. Epub 2013 Nov 8.
2
Nano-SAR development for bioactivity of nanoparticles with considerations of decision boundaries.纳米 SAR 发展考虑决策边界的纳米粒子生物活性。
Small. 2013 May 27;9(9-10):1842-52. doi: 10.1002/smll.201201903. Epub 2013 Feb 19.
3
Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential.应用定量构效关系方法于纳米毒理学:现状与未来潜力。
Toxicology. 2013 Nov 8;313(1):15-23. doi: 10.1016/j.tox.2012.11.005. Epub 2012 Nov 16.
4
Modeling biological activities of nanoparticles.纳米粒子的生物活性建模。
Nano Lett. 2012 Nov 14;12(11):5808-12. doi: 10.1021/nl303144k. Epub 2012 Oct 9.
5
Advancing risk assessment of engineered nanomaterials: application of computational approaches.推进工程纳米材料风险评估:计算方法的应用。
Adv Drug Deliv Rev. 2012 Dec;64(15):1663-93. doi: 10.1016/j.addr.2012.05.014. Epub 2012 Jun 1.
6
Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation.利用金属氧化物纳米颗粒带隙开发氧化应激和急性肺炎症的预测模式。
ACS Nano. 2012 May 22;6(5):4349-68. doi: 10.1021/nn3010087. Epub 2012 Apr 24.
7
Mapping the surface adsorption forces of nanomaterials in biological systems.绘制生物体系中纳米材料的表面吸附力图谱。
ACS Nano. 2011 Nov 22;5(11):9074-81. doi: 10.1021/nn203303c. Epub 2011 Oct 27.
8
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.治疗性脂质体和其他基于脂质赋形剂的治疗产品激活补体:预测和预防。
Adv Drug Deliv Rev. 2011 Sep 16;63(12):1020-30. doi: 10.1016/j.addr.2011.06.017. Epub 2011 Jul 14.
9
Classification NanoSAR development for cytotoxicity of metal oxide nanoparticles.分类:金属氧化物纳米颗粒细胞毒性的纳 SAR 开发。
Small. 2011 Apr 18;7(8):1118-26. doi: 10.1002/smll.201002366. Epub 2011 Mar 24.
10
Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles.利用纳米定量构效关系预测金属氧化物纳米颗粒的细胞毒性。
Nat Nanotechnol. 2011 Mar;6(3):175-8. doi: 10.1038/nnano.2011.10. Epub 2011 Feb 13.